Table 5.

Subgroup analysis of eGFR abnormality adjusting for age in different groups.

Variance		β	SE	Exp β	95% CI	P value
Model 1	Group (control) (Ref)					0.002
	Group (cfPWV/CBP)	1.769	0.492	5.867	2.236–15.393	<0.001
	Group (cfPWV)	0.851	0.672	2.342	0.627–8.741	0.205
	Group (CBP)	0.051	0.598	1.052	0.326–3.397	0.932
Model 2	Age (≥60 years)	0.943	0.456	2.567	1.049–6.279	0.039
	Group (control) (Ref)					0.042
	Group (cfPWV/CBP)	1.391	0.524	4.019	1.439–11.229	0.008
	Group (cfPWV)	0.350	0.709	1.418	0.353–5.695	0.622
	Group (CBP)	−0.007	0.600	0.993	0.306–3.219	0.990

Model 1 adjusted for sex (male or female), height, BMI, body mass index, smoking history, antihypertensive drugs (yes or no), high-density lipoprotein cholesterol HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; HbA1c, hemoglobinA1c; HR, heart rate; p-MAP,peripheral mean arterial pressure, and groups.

Model 2 adjusted for sex, height, BMI, smoking history, antihypertensive drugs (yes or no), HDL-c, LDL-c, HbA1c, heart rate, p-MAP, groups, and age.

The bold values represent the values that are statistically significant (P < 0.05).